Sanara MedTech Inc. (SMTI) P/E Ratio History
Deep ValueTrading at -5.1x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2017–2018
Loading P/E history...
P/E Ratio Analysis
As of June 21, 2026, Sanara MedTech Inc. (SMTI) trades at a price-to-earnings ratio of -5.1x, with a stock price of $22.02 and trailing twelve-month earnings per share of $-3.74.
The current P/E is 125% below its 5-year average of 20.1x. Over the past five years, SMTI's P/E has ranged from a low of 12.9x to a high of 30.9x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.1x, SMTI trades at a 123% discount to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.
Relative to the broader market, SMTI trades at a notable discount to the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our SMTI DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
SMTI Cross-Benchmark Valuation
How does the current P/E compare to sector peers and the broader market?
SMTI P/E vs Peers
Wound care and infection prevention peers sorted by market cap
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $62M | 14.7 | - | +125% | |
| $545M | 11.5 | - | +14% | |
| $341M | 4.6Lowest | - | +146%Best | |
| $5B | 724.8 | - | -48% | |
| $24B | 48.2 | 5.83Best | +2% | |
| $17B | 30.5 | - | -25% |
Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.
SMTI Historical P/E Data (2017–2018)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Period End | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2018 Q3 | Sep 30 2018 | $7.00 | $0.33 | 21.4x | +6% |
| FY2018 Q2 | Jun 30 2018 | $7.00 | $0.35 | 20.1x | +0% |
| FY2018 Q1 | Mar 31 2018 | $5.00 | $0.37 | 13.6x | -32% |
| FY2017 Q4 | Dec 31 2017 | $6.00 | $0.47 | 12.9x | -36% |
| FY2017 Q3 | Sep 30 2017 | $7.00 | $0.23 | 30.9x | +54% |
| FY2017 Q2 | Jun 30 2017 | $8.00 | $0.37 | 21.7x | +8% |
Average P/E for displayed period: 20.1x
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
9+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
SMTI — Frequently Asked Questions
Quick answers to the most common questions about buying SMTI stock.
What is SMTI's P/E ratio?
Sanara MedTech Inc. (SMTI) trailing twelve-month P/E ratio is -5.1x, based on TTM diluted EPS of $-3.74. The 5-year average P/E is 20.1x and the historical range spans 12.9x to 30.9x.
Is SMTI stock overvalued or undervalued?
SMTI trades at -5.1x P/E, below its 5-year average of 20.1x. At the 0th percentile of its historical range (12.9x–30.9x), the stock is priced at a discount to its own history.
Is SMTI stock expensive?
No, SMTI is not expensive on a historical basis. The current P/E of -5.1x is below the 5-year average of 20.1x and sits at the 0th percentile of its valuation range.
What is SMTI's historical P/E range?
Over the past 5 years, SMTI's P/E ratio has ranged from 12.9x to 30.9x, with a median of 21.4x and an average of 20.1x. The current P/E of -5.1x places the stock at the 0th percentile of this range. Full historical data spans 2017–2018.
How does SMTI's P/E compare to the S&P 500?
SMTI trades at -5.1x P/E versus the S&P 500 median of 24.4x. The 121% discount to the market suggests lower growth expectations or perceived higher risk.
How does SMTI's valuation compare to Healthcare peers?
Sanara MedTech Inc. P/E of -5.1x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.
What is SMTI's PEG ratio?
SMTI PEG ratio is N/A, based on a P/E of -5.1x and EPS growth of -282.5%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.
What is SMTI's earnings yield?
SMTI earnings yield is N/A, the inverse of its -5.1x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.